Credo Technology (CRDO) shares have more than doubled in the last five months, driven by exceptional operational execution, two consecutive beat-and-raise quarters, and strong demand for its Active Electrical Cables (AECs), which also contributed to significant customer diversification. The company issued robust guidance, projecting over 120% revenue growth for fiscal 2026, well above consensus. However, the stock's valuation is now significantly extended, with its price-to-sales ratio in the mid-40s, prompting a 'hold' recommendation despite continued strong fundamentals and favorable market conditions, due to increased vulnerability to corrections.
Credo Technology (CRDO) has demonstrated exceptional operational execution, leading to its stock price more than doubling in the last five months. The company's revenue beats have accelerated significantly, averaging 11.1% above the guidance midpoint in the last four quarters compared to 1.6% previously, driven by strong demand for its Active Electrical Cables (AECs) amid trends like GPU densification. A critical positive development is the substantial reduction in customer concentration; reliance on Amazon has fallen from 84% of revenue two quarters ago to a more balanced split among three hyperscalers contributing 35%, 33%, and 20% respectively, with a fourth major customer expected to emerge this fiscal year. This fundamental strength is reflected in a robust fiscal 2026 forecast of 120% year-over-year revenue growth, well ahead of the 86% consensus. However, this performance has pushed the valuation to an extended level, with the price-to-sales ratio expanding into the mid-40s. The stock is also technically overbought, trading more than 80% above its 200-day moving average, which increases its vulnerability to significant corrections on any perceived slowdown or even in-line performance.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment